Back
The Scotts Miracle Gro Vs. Akero Therapeutics Industry Stock Comparison
Buy
60
SMG
The Scotts Miracle Gro
Last Price:
$64.09
Seasonality Move:
-1.51%
Buy
66
AKRO
Akero Therapeutics
Last Price:
$52.94
Seasonality Move:
26.74%
Buy
60
The Scotts Miracle Gro (SMG)
is a Buy
Is The Scotts Miracle Gro a Buy, Sell or Hold?
-
The current The Scotts Miracle Gro [SMG] share price is $64.04. The Score for SMG is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
-
SMG is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
66
Akero Therapeutics (AKRO)
is a Buy
Is Akero Therapeutics a Buy, Sell or Hold?
-
The current Akero Therapeutics [AKRO] share price is $54.52. The Score for AKRO is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
-
AKRO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
SMG Stock Price Chart
What is The Scotts Miracle Gro's stock price today?
-
The The Scotts Miracle Gro share price today is $64.04Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SMG is experiencing selling pressure, which indicates risk of future bearish movement.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $54.52The current trend is moderately bullish and AKRO is experiencing buying pressure, which is a positive indicator for future bullish movement.
SMG Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.95 | Buy |
Relative Strength Index (14 RSI): | 60.24 | Buy |
Chaikin Money Flow: | -953399 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (56.56 - 63.32) | Buy |
Bollinger Bands (100): | (53.86 - 67.14) | Buy |
AKRO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.33 | Buy |
Relative Strength Index (14 RSI): | 70.35 | Buy |
Chaikin Money Flow: | 708985 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (40.73 - 51.79) | Buy |
Bollinger Bands (100): | (35.84 - 51.64) | Buy |
SMG Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 61.75 | Buy |
20-day SMA: | 61.17 | Buy |
50-day SMA: | 56.33 | Buy |
200-day SMA: | 68.38 | Sell |
8-day EMA: | 62.86 | Buy |
20-day EMA: | 60.77 | Buy |
50-day EMA: | 59.14 | Buy |
200-day EMA: | 64.1 | Sell |
AKRO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 52.8 | Buy |
20-day SMA: | 47.39 | Buy |
50-day SMA: | 42.93 | Buy |
200-day SMA: | 36.38 | Buy |
8-day EMA: | 52.61 | Buy |
20-day EMA: | 49 | Buy |
50-day EMA: | 45.35 | Buy |
200-day EMA: | 38.09 | Buy |
The Scotts Miracle Gro Earnings Growth & SMG Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.37 per share, an increase next quarter of $3.53 per share, an increase this year of $0.95 per share, and an increase next year of $0.76 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.18 per share, and a decrease next year of $0.64 per share.
The Scotts Miracle Gro Technical Analysis
May 28 | May 29 | May 30 | Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 9 | Jun 10 | |
---|---|---|---|---|---|---|---|---|---|---|
May | Jun | |||||||||
28 | 29 | 30 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Akero Therapeutics Technical Analysis
May 28 | May 29 | May 30 | Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 9 | Jun 10 | |
---|---|---|---|---|---|---|---|---|---|---|
May | Jun | |||||||||
28 | 29 | 30 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |